Reuters logo
3 个月前
BRIEF-AstraZeneca says Leo Pharma has received positive opinion from CHMP of EMA recommending approval of Brodalumab
2017年5月19日 / 下午4点39分 / 3 个月前

BRIEF-AstraZeneca says Leo Pharma has received positive opinion from CHMP of EMA recommending approval of Brodalumab

May 19 (Reuters) - AstraZeneca Plc :

* Brodalumab receives positive chmp opinion for treatment of adult patients with moderate-to-severe plaque psoriasis

* co's partner Leo Pharma has received positive opinion from CHMP of EMA recommending approval of Brodalumab Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below